Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Status:
Terminated
Trial end date:
2020-07-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and safety of the NovoTTF-200A device
in patients with low-grade glioma when it's used by itself or used together with
temozolomide. Researchers would also like to know whether the use of NovoTTF-200A, with or
without temozolomide, is associated with fewer negative side effects on mental function that
may be seen with other currently used treatment options.